These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38929363)

  • 1. Duration of Protection and Humoral Immune Response in Nile Tilapia (
    Queiróz GA; Silva TMFE; Leal CAG
    Animals (Basel); 2024 Jun; 14(12):. PubMed ID: 38929363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
    Pasnik DJ; Evans JJ; Klesius PH
    Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity in Oreochromis niloticus vaccinated with sonicated antigens against streptococcosis.
    Marcusso PF; da Silva Claudiano G; Yunis-Aguinaga J; de Almeida Marinho-Neto F; Eto SF; Fernandes DC; Rosolem MC; Salvador R; Engracia de Moraes JR; Ruas de Moraes F
    Fish Shellfish Immunol; 2021 Aug; 115():134-141. PubMed ID: 34098067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of MONTANIDE™ GR01, a new adjuvant for feed-based vaccines, on the immune response and protection against Streptococcus agalactiae in oral vaccinated Nile tilapia (Oreochromis niloticus) under laboratory and on-farm conditions.
    Pholchamat S; Vialle R; Luang-In V; Phadee P; Wang B; Wang T; Secombes CJ; Wangkahart E
    Fish Shellfish Immunol; 2024 Jun; 149():109567. PubMed ID: 38641215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effects of Montanide™ ISA 763A VG and ISA 763B VG adjuvants on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
    Wangkahart E; Thongsrisuk A; Vialle R; Pholchamat S; Sunthamala P; Phudkliang J; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2023 Mar; 134():108563. PubMed ID: 36717067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts.
    Suwanbumrung D; Wongkhieo S; Keaswejjareansuk W; Dechbumroong P; Kamble MT; Yata T; Kitiyodom S; Rodkhum C; Thompson KD; Namdee K; Pirarat N
    Fish Shellfish Immunol; 2023 Aug; 139():108913. PubMed ID: 37393062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia,
    Amrullah A; Wahidah W; Ardiansyah A; Indrayani I
    F1000Res; 2021; 10():966. PubMed ID: 37767359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
    Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
    Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
    Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
    Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
    Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-protective efficiency of feed-based whole-cell inactivated bivalent vaccine against Streptococcus and Aeromonas infections in red hybrid tilapia (Oreochromis niloticus × Oreochromis mossambicus).
    Monir MS; Yusoff MSM; Zulperi ZM; Hassim HA; Zamri-Saad M; Amal MNA; Salleh A; Mohamad A; Yie LJ; Ina-Salwany MY
    Fish Shellfish Immunol; 2021 Jun; 113():162-175. PubMed ID: 33857622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
    Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
    Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus).
    Pridgeon JW; Klesius PH
    Vaccine; 2011 Aug; 29(35):5986-93. PubMed ID: 21708205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).
    Wong KY; Megat Mazhar Khair MH; Song AAL; Masarudin MJ; Loh JY; Chong CM; Beardall J; Teo MYM; In LLA
    Fish Shellfish Immunol; 2024 Jun; 149():109572. PubMed ID: 38636739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil.
    Delphino MKVC; Barone RSC; Leal CAG; Figueiredo HCP; Gardner IA; Gonçalves VSP
    Prev Vet Med; 2019 Jan; 162():131-135. PubMed ID: 30621892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
    Nur-Nazifah M; Sabri MY; Siti-Zahrah A
    Fish Shellfish Immunol; 2014 Mar; 37(1):193-200. PubMed ID: 24486904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
    Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
    Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Streptococcus agalactiae concentration on immune system and effective dose of inactivated vaccine for Chitralada 3 strain Nile tilapia (Oreochromis niloticus) in Thailand.
    Khunrang T; Pooljun C; Wuthisuthimethavee S
    BMC Vet Res; 2023 Dec; 19(1):267. PubMed ID: 38082432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feed-based vaccination regime against streptococcosis in red tilapia, Oreochromis niloticus x Oreochromis mossambicus.
    Ismail MS; Siti-Zahrah A; Syafiq MR; Amal MN; Firdaus-Nawi M; Zamri-Saad M
    BMC Vet Res; 2016 Sep; 12(1):194. PubMed ID: 27608936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.